{'fraction_non_alphanumeric': 0.026426426426426425, 'fraction_numerical': 0.016816816816816817, 'mean_word_length': 5.239700374531835, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Drug Utilization Analysis of Anticoagulant and Antiplatelet Drugs in Cardiology Department of a Tertiary Care Hospital

Background: The current study was planned to estimate the usage of antiplatelet drugs and anticoagulant drugs patients in the teaching hospital. Methods: The records were composed through the Cardiology ward / Cardiac care unit (CCU) on regular basis after receiving agreement from the Institutional Ethics Committee (IEC). The documents pooling layout was generated and validated by giving inclination to drugs used by Coronary artery disease (CAD), Ischemic heart disease (IHD), Angina pectoris, Arterial fibrillation. Data of patient’s identical inclusion criteria were noted. Results: An overall of 210 patients was included in the study giving an overview of the characteristics of the patients and prescriptions. In this study, the total number of male patients was found to be 118, and the number of female patients was 92. Coronary artery disease was observed to be more common in males (56.2%) than in females (43.8%). A total of 210 patients were taken for the study and patients were categorized according to their age group and gender. Conclusion: It was concluded that drug utilization of antiplatelet and anticoagulant drugs was 92.8% and 63.80% respectively achieved in the tertiary care hospital in Northern India Jan-June 2021. Aspirin and Ticagrelor were the frequently used antiplatelet drugs whereas Heparin and Enoxaparin were the most used anticoagulant drugs in MMIMSR, Ambala. This study gives an idea for conducting Drug utilization review on antiplatelet and anticoagulants drugs with improved and better understanding.